Dihematoporphyrin Ether [dihematoporfyrinether]
- Terms
-
DHP Ether
Dihematoporphyrin Ester
Photofrin
Photofrin II
Porfimer
Porfimer Sodium
The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.
- DUI
- D017323 MeSH Browser
- CUI
- M0026307
- CAS
- 21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-
- Previous indexing
- Hematoporphyrins (1985-1992)
- History note
- 93; was DIHEMATOPORPHYRIN ETHER (NM) 1985-92
- Online note
- use DIHEMATOPORPHYRIN ETHER (NM) to search DIHEMATOPORPHYRIN ETHER 1985-92
- Public note
- 93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UR
- urine